日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort.

内皮细胞 pY397-FAK 表达可预测 SweBCG91-RT 队列中乳腺癌放疗后复发的风险

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-2939
Drake Rebecca J G, Landén Amalia H, Holmberg Erik, Stenmark Tullberg Axel, Killander Fredrika, Niméus Emma, Jordan Alexander, McGuinness Jennifer, Karlsson Per, Hodivala-Dilke Kairbaan
细胞生物学
FAK
肿瘤免疫
发表日期：2025
文献求助 收藏

Predicting immune responsiveness in ER-positive breast cancer for personalized therapy: a population-based study

预测ER阳性乳腺癌患者的免疫反应以实现个体化治疗：一项基于人群的研究

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-025-01035-z
Stenmark Tullberg, Axel; Woxlin, Sara; Sjölin, Filippa; Ittner, Ella; Kovàcs, Anikò; Helou, Khalil; Holmberg, Erik; Karlsson, Per
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial

肿瘤 pSMAD2 作为早期乳腺癌的预后生物标志物：来自随机 SweBCG91RT 试验的启示

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-025-07744-0
Stenmark Tullberg, Axel; Thurfjell, Viktoria; Kovács, Anikó; Micke, Patrick; Moustakas, Aristidis; Killander, Fredrika; Niméus, Emma; Holmberg, Erik; Karlsson, Per; Strell, Carina
SMAD2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial

结合组织学分级、肿瘤浸润淋巴细胞（TILs）和PD-1/PD-L1通路来识别免疫原性肿瘤并降低早期乳腺癌的放疗强度：一项随机临床试验的二次分析

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-006618
Stenmark Tullberg, Axel; Sjöström, Martin; Tran, Lena; Niméus, Emma; Killander, Fredrika; Kovács, Anikó; Lundstedt, Dan; Holmberg, Erik; Karlsson, Per
肿瘤
肿瘤免疫
信号转导
乳腺癌
PD-L1
细胞生物学
PD-1
免疫/内分泌
发表日期：2023
文献求助 收藏

Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial

整合肿瘤内在因素和免疫因素以从低风险人群中识别免疫原性乳腺癌：来自随机SweBCG91RT试验的结果

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-2746
Stenmark Tullberg, Axel; Sjöström, Martin; Niméus, Emma; Killander, Fredrika; Chang, S Laura; Feng, Felix Y; Speers, Corey W; Pierce, Lori J; Kovács, Anikó; Lundstedt, Dan; Holmberg, Erik; Karlsson, Per
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2023
文献求助 收藏